MedPath
FDA Approval

Tobramycin and Dexamethasone

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
July 11, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Tobramycin(3 mg in 1 mL)
Dexamethasone(1 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

A-S Medication Solutions

A-S Medication Solutions

830016429

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tobramycin and Dexamethasone

Product Details

NDC Product Code
50090-1135
Application Number
NDA050592
Marketing Category
NDA authorized generic (C73605)
Route of Administration
OPHTHALMIC
Effective Date
May 29, 2018
Code: VZ8RRZ51VKClass: ACTIBQuantity: 3 mg in 1 mL
Code: 7S5I7G3JQLClass: ACTIBQuantity: 1 mg in 1 mL
TYLOXAPOLInactive
Code: Y27PUL9H56Class: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
SODIUM SULFATEInactive
Code: 0YPR65R21JClass: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCFClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7Class: IACT
HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)Inactive
Code: S38J6RZN16Class: IACT
© Copyright 2025. All Rights Reserved by MedPath